Novel Coronavirus (SARS-CoV-2/COVID-19)
An AHA advertorial published in the Wall Street Journal highlights the growing challenges facing the nation’s health care workforce, how America’s hospitals and health systems are working to support them, and the need for policymakers at every level of government to do the same.
The AHA released its latest edition of the COVID-19 Snapshot underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
President Biden announced his plan for responding to COVID-19 surges and the new omicron variant this winter.
The California and San Francisco Departments of Public Health have confirmed the first case of the omicron variant in the United States in an individual in California who was fully vaccinated against COVID-19 and returned Nov. 22 from South Africa, the Centers for Disease Control and Prevention…
The Centers for Medicare & Medicaid Services last week released a FAQ clarifying when the Clinical Laboratory Improvement Amendments apply to over-the-counter home tests, including COVID-19 tests.
Twenty-five organizations, including the AHA, urge Congress to immediately extend the hold on payment cuts and private payer data reporting period under the Clinical Laboratory Fee Schedule due to the continued COVID-19 public health emergency.
President Biden today called the new Omicron variant of the COVID-19 virus “a cause for concern, not a cause for panic,” urging all eligible Americans to get vaccinated and all eligible adults to get a booster if they haven’t already.
The Department of Health and Human Services (HHS) today began distributing $7.5 billion of the $8.5 billion in American Rescue Plan Act (ARPA) payments designated for providers who serve rural Medicaid, Children’s Health Insurance Program (CHIP), and Medicare beneficiaries.
A two-dose series of the Pfizer-BioNTech COVID-19 vaccine was 100% effective against COVID-19 in 12-14 year olds more than four months after the second dose in the companies’ phase 3 clinical trial, Pfizer and BioNTech announced.
The Department of Health and Human Services began distributing $7.5 billion of the $8.5 billion in American Rescue Plan Act payments designated for providers who serve rural Medicaid, Children’s Health Insurance Program, and Medicare beneficiaries.